Hemp seed oil - change of status

An interim decision has been made to exclude hemp seed oil from Schedule 9 of the poisons schedule whe used for oral consumption and when compliant with the Food Standards Code. Schedule 9 includes "Prohibited Substances". Hemp seed oil is not yet available for use in listed complemetary medicines, but that may change if an application is submitted to the TGA to have it added to the list of permitted ingredients. Full details including restrictions that apply can be viewed in this link.    Source: TGA


Compliance enforcement

Lorna Jane pays $5 million fine. In our January newsletter we reported "the ACCC takes Lorna Jane to court over 'Anti-virus Activewear' claims". The claims made by Lorna Jane about its LJ Shield Activewear included "Cure for the Spread of COVID-19? Lorna Jane Thinks So" and "LJ SHIELD is a groundbreaking technology that makes transferal of all pathogens to your Activewear (and let's face it, the one we're all thinking about is Covid-19) impossible by eliminating the virus on contact with the fabric". Lorna Jane also admitted that it had falsely represented it had a scientific or technological basis for making the 'anti-virus' claims about its LJ Shield Activewear, when no such basis existed. They also admitted that director and Chief Creative Officer, Ms Lorna Jane Clarkson, authorised and approved the LJ Shield Activewear promotional material, was involved in crafting the words and developing the imagery used in the marketing campaign, and personally made some of the false statements contained in a media release and an Instagram video.    Source: ACCC

Starpharma Holdings Limited fined $93,240 for alleged unlawful advertising of 'Viraleze' in relation to COVID-19. The TGA issued 7 infringement notices, the product was a nasal spray not registered in Australia and contained claims that it “..  that stops SARS-CoV-2, the virus that causes COVID-19”.    Source: TGA

Canberra person fined $2,664 for alleged unlawful advertising of a homoeopathic medicine in relation to COVID-19 -.    Source: TGA

Sydney person fined $10,656 for alleged unlawful advertising of medicinal cannabis. The product was not registered with the TGA, and was being marketed with claims for Alzheimer’s Disease, and as a treatment for “cancerous tumours”.    Source: TGA


Proprietary ingredients – streamlined process

TGA has implemented changes as a result of public consultation on the proposal to discontinue entering certain types of ingredient mixtures into the Proprietary Ingredients Table before they are selected into therapeutic goods applications. This proposal was limited to ingredient mixtures that contain an active ingredient (known as ‘Active Premixes’ and ‘Active Herbal Extracts’), and non-specific ‘Excipient mixes’, which do not provide sufficient information on the purpose of the mixture. The majority of respondents supported the proposal to stop processing new Active Premixes, Active Herbal Extracts, and non-specific ‘Excipient mixes’ into the Proprietary ingredients Table.     Source: TGA


New compositional guidelines

The TGA creates compositional guidelines for ingredients permitted in listed medicines that do not have a pharmacopoeial monograph. Recently published guidelines are:

Bacillus coagulans strain MTCC 5260     Source: TGA

Bittern     Source: TGA

Chondroitin Sulphate Sodium derived from fermentation of Escherichia coli     Source: TGA

Palmidrol     Source: TGA

2'-Fucosyllactose    Source: TGA


Nicotine vaping products and vaping devices

A new standard has been published - Guidance for Therapeutic Goods (Standard for Nicotine Vaping Products) Order 110 2021 (TGO 110). This is to help health practitioners, consumers, importers and other sponsors, wholesalers and manufacturers to understand the minimum safety and quality requirements that apply to unregistered products.    Source: TGA


Update on consultation on proposed enhancements to adverse event reporting for medical devices

A summary of industry and individual consumer responses to the survey has been published on the TGA Consultation Hub. The survey findings indicate that follow-up discussions should occur on some of the proposed options.    Source: TGA


Software – when is it a medical device and when is it not?

This guidance contains flow charts showing which products are regulated as medical devices, and which ones are not.    Source: TGA


Some medical devices to be re-classified

This is a project underway to investigate reclassifying a number of categories of medical devices so that they align, wherever possible, with the changes being introduced in European Union (EU) medical devices framework.    Source: TGA


Further refinement to medical device regulatory changes

TGA is seeking comment on substances that are made to go on the skin, or inside the body through an orifice, and are absorbed or dispersed. These products may fit the definition of a medicine as well as a medical device. Proposed refinements are to address this issue.    Source: TGA


ACCESS consortium of international health agencies

The TGA is a member of the Access consortium along with Health Canada, Health Sciences Authority of Singapore, Swissmedic and the UK's Medicines and Healthcare products Regulatory Agency (MHRA). The consortium's goal is to maximise international cooperation, reduce duplication, and increase each agency's capacity to ensure consumers have timely access to high quality, safe and effective therapeutic products.    Source: TGA


Amazon requires sellers of “dietary supplements” to comply with Australian regulations

Some of Amazon’s requirements include “All products must be intended for sale within Australia and comply with all laws and regulations of Australia…… All products must have an ARTG number (where required by Australian law)".    Source: Amazon

Join our Newsletter

catchme refresh

Spambot Captcha Protection
Joomla Extensions powered by Joobi
Go to top